Senior Director
WuXi AppTec
Nan Zhao, Ph.D., is Senior Director of Drug Metabolism and Pharmacokinetics (DMPK) at WuXi AppTec in New Jersey, where she leads discovery bioanalysis teams supporting preclinical in vitro and in vivo pharmacokinetic studies. She has over 10 years of experience across global CRO and biotechnology environments, with technical expertise in bioanalytical method development and emerging therapeutic modalities. Previously, she held leadership roles at Resolian and WuXi AppTec in Shanghai, and scientific positions at Stoke Therapeutics and Covance. She is recognized for advancing analytical capabilities and translating DMPK data into informed development decisions. Dr. Zhao holds a Ph.D. in Biophysics from Georgia State University.
Disclosure information not submitted.
Bioanalysis for Emerging Modalities: From Exploratory Innovation to Regulatory-Ready Strategies
Wednesday, July 15, 2026
8:05 AM - 8:35 AM East Coast USA Time